Response of Foot-and-Mouth Disease Virus to Increased Mutagenesis: Influence of Viral Load and Fitness in Loss of Infectivity
暂无分享,去创建一个
Pedro R. Lowenstein | E. Domingo | P. Lowenstein | M. Dávila | S. Sierra | Saleta Sierra | Mercedes Dávila | Esteban Domingo | M. Dávila
[1] S. Halle. 5-Azacytidine as a mutagen for arboviruses , 1968, Journal of virology.
[2] F. Šorm,et al. Incorporation of 5-azacytidine into nucleic acids of Escherichia coli. , 1968, Biochimica et biophysica acta.
[3] C. Pringle. Genetic Characteristics of Conditional Lethal Mutants of Vesicular Stomatitis Virus Induced by 5-Fluorouracil, 5-Azacytidine, and Ethyl Methane Sulfonate , 1970, Journal of virology.
[4] E. Batschelet,et al. The proportion of revertant and mutant phage in a growing population, as a function of mutation and growth rate. , 1976, Gene.
[5] M. Oldstone,et al. Temperature-sensitive mutants of mouse hepatitis virus produce a high incidence of demyelination. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[6] M. Eigen,et al. The Hypercycle: A principle of natural self-organization , 2009 .
[7] E. Domingo,et al. Nucleotide sequence heterogeneity of the RNA from a natural population of foot-and-mouth-disease virus. , 1980, Gene.
[8] P. Schuster,et al. Self-replication with errors. A model for polynucleotide replication. , 1982, Biophysical chemistry.
[9] M. Linial,et al. 7 Genetics of Retroviruses , 1982 .
[10] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[11] E. Domingo,et al. Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. , 1983, Virology.
[12] E. Domingo,et al. Sequence of the viral replicase gene from foot-and-mouth disease virus C1-Santa Pau (C-S8). , 1985, Gene.
[13] C. Blair,et al. Temperature-sensitive mutants of Japanese encephalitis virus , 1985, Journal of virology.
[14] E. Domingo,et al. Establishment of cell lines persistently infected with foot-and-mouth disease virus. , 1985, Virology.
[15] J. Skoda,et al. Azapyrimidine nucleosides: metabolism and inhibitory mechanisms. , 1985, Advances in enzyme regulation.
[16] B. Leyland-Jones,et al. Biochemistry of azacitidine: a review. , 1987, Cancer treatment reports.
[17] M. Eigen,et al. Molecular quasi-species. , 1988 .
[18] E. Domingo,et al. Coevolution of cells and viruses in a persistent infection of foot-and-mouth disease virus in cell culture , 1988, Journal of virology.
[19] D. Taylor,et al. Multiple spectral parameter imaging. , 1989, Methods in cell biology.
[20] J. Miller,et al. A set of lacZ mutations in Escherichia coli that allow rapid detection of each of the six base substitutions. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[21] V. Pathak,et al. Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[22] David A. Steinhauer,et al. Mutation Frequencies at Defined Single Codon Sites in Vesicular Stomatitis Virus and Poliovirus Can Be Increased Only Slightly by Chemical Mutagenesis , 1990, Journal of virology.
[23] Miguel Ángel Martínez,et al. A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. , 1990, The Journal of general virology.
[24] Y. Cheng,et al. Metabolism and mechanism of action of 5-fluorouracil. , 1990, Pharmacology & therapeutics.
[25] E. Domingo,et al. Two mechanisms of antigenic diversification of foot-and-mouth disease virus. , 1991, Virology.
[26] J. Holland,et al. RNA virus populations as quasispecies. , 1992, Current topics in microbiology and immunology.
[27] Miguel Ángel Martínez,et al. Evolution of the capsid protein genes of foot-and-mouth disease virus: antigenic variation without accumulation of amino acid substitutions over six decades , 1992, Journal of virology.
[28] V. Pathak,et al. 5-Azacytidine and RNA secondary structure increase the retrovirus mutation rate , 1992, Journal of virology.
[29] R. Eritja,et al. Ionization of bromouracil and fluorouracil stimulates base mispairing frequencies with guanine. , 1993, The Journal of biological chemistry.
[30] E. Domingo,et al. Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection , 1993, Journal of virology.
[31] D. Stuart,et al. The structure and antigenicity of a type C foot-and-mouth disease virus. , 1994, Structure.
[32] Miguel Ángel Martínez,et al. Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites , 1994, Journal of virology.
[33] S. Elena,et al. Extreme fitness differences in mammalian and insect hosts after continuous replication of vesicular stomatitis virus in sandfly cells , 1995, Journal of virology.
[34] D. Kuritzkes,et al. Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic Millimeter , 1995 .
[35] W. Ebeling,et al. Physical Approaches to Biological Evolution , 1995 .
[36] E. Domingo,et al. Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy , 1995, Journal of virology.
[37] H. Temin. Genetics of Retroviruses a , 1995, Annals of the New York Academy of Sciences.
[38] A. Moya,et al. Genetic lesions associated with Muller's ratchet in an RNA virus. , 1996, Journal of molecular biology.
[39] E. Domingo,et al. Long-term, large-population passage of aphthovirus can generate and amplify defective noninterfering particles deleted in the leader protease gene. , 1996, Virology.
[40] M. Wainberg,et al. Enhanced Fidelity of 3TC-Selected Mutant HIV-1 Reverse Transcriptase , 1996, Science.
[41] R. Rueckert. Picornaviridae: The viruses and their replication , 1996 .
[42] J. Braman,et al. PCR fidelity of pfu DNA polymerase and other thermostable DNA polymerases. , 1996, Nucleic acids research.
[43] J W Mulder,et al. Virologic and immunologic benefits of initial combination therapy with zidovudine and zalcitabine or didanosine compared with zidovudine monotherapy. Wellcome Resistance Study Collaborative Group. , 1996, The Journal of infectious diseases.
[44] E. Domingo,et al. Human immunodeficiency virus type 1 reverse transcriptase: role of Tyr115 in deoxynucleotide binding and misinsertion fidelity of DNA synthesis. , 1996, The EMBO journal.
[45] B. Preston,et al. Mechanisms of retroviral mutation. , 1996, Trends in microbiology.
[46] M. Paul. The immune system in vertical HIV infection: the immune response and disease progression. , 1997, AIDS research and human retroviruses.
[47] J. Hansen,et al. Structure of the RNA-dependent RNA polymerase of poliovirus. , 1997, Structure.
[48] E A Emini,et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. , 1997, The New England journal of medicine.
[49] E. Domingo,et al. Negative effects of chemical mutagenesis on the adaptive behavior of vesicular stomatitis virus , 1997, Journal of virology.
[50] M A Fischl,et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. , 1997, The New England journal of medicine.
[51] Miguel Ángel Martínez,et al. Differential restrictions on antigenic variation among antigenic sites of foot-and-mouth disease virus in the absence of antibody selection. , 1997, The Journal of general virology.
[52] E. Domingo,et al. An RNA virus can adapt to the multiplicity of infection. , 1998, The Journal of general virology.
[53] P. Schuster,et al. Nature and Evolution of Early Replicons , 1998 .
[54] E. Domingo,et al. Multiple Virulence Determinants of Foot-and-Mouth Disease Virus in Cell Culture , 1998, Journal of Virology.
[55] J. Drake,et al. Mutation rates among RNA viruses. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[56] J. Mullins,et al. Lethal mutagenesis of HIV with mutagenic nucleoside analogs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[57] C. Cupples,et al. Effect of interaction between 5-azacytidine and DNA (cytosine-5) methyltransferase on C-to-G and C-to-T mutations in Escherichia coli. , 1999, Mutation research.
[58] C. Boucher,et al. Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy. , 1999, AIDS.
[59] E. Domingo,et al. Genomic nucleotide sequence of a foot-and-mouth disease virus clone and its persistent derivatives. Implications for the evolution of viral quasispecies during a persistent infection. , 1999, Virus research.
[60] E. Domingo,et al. Multiple molecular pathways for fitness recovery of an RNA virus debilitated by operation of Muller's ratchet. , 1999, Journal of molecular biology.
[61] J. Mullins,et al. Lethal mutagenesis of HIV by mutagenic ribonucleoside analogs. , 2000, AIDS research and human retroviruses.
[62] V. Racaniello. Picornaviridae : the viruses and their replication , 2001 .
[63] E. Domingo,et al. Foot-and-mouth disease virus. , 2002, Comparative immunology, microbiology and infectious diseases.